Besch Doug has filed 24 insider transactions across 1 company since October 2023.
Most recent transaction: a tax payment of 4079 shares of OptimizeRx Corp ($OPRX) on December 23, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 23, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product & Tech Officer | F | Common Stock | 4079 | $12.74 | 66,876.0000 | 20,333,839 | 5.75% | 0.02% |
| Dec. 19, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product & Tech Officer | M | Restricted Stock Units | 1964 | $0.00 | 1,964.0000 | 20,333,839 | 50.00% | 0.01% |
| Dec. 19, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product & Tech Officer | F | Common Stock | 581 | $13.51 | 70,955.0000 | 20,333,839 | 0.81% | 0.00% |
| Dec. 19, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product & Tech Officer | M | Common Stock | 1964 | $0.00 | 71,536.0000 | 20,333,839 | 2.82% | 0.01% |
| Oct. 3, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product & Tech Officer | F | Common Stock | 983 | $18.75 | 69,572.0000 | 20,333,839 | 1.39% | 0.00% |
| Oct. 3, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product & Tech Officer | M | Restricted Stock Units | 3325 | $0.00 | 0.0000 | 20,333,839 | 100.00% | 0.02% |
| Oct. 3, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product & Tech Officer | M | Common Stock | 3325 | $0.00 | 70,555.0000 | 20,333,839 | 4.95% | 0.02% |
| Aug. 21, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Prod & Tech Officer | A | Common Stock | 15625 | $0.00 | 67,230.0000 | 20,297,388 | 30.28% | 0.08% |
| Aug. 21, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Prod & Tech Officer | A | Stock Option | 35156 | $0.00 | 35,156.0000 | 20,297,388 | 9999.99% | 0.17% |
| Feb. 15, 2025 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | F | Common Stock | 1386 | $6.64 | 51,605.0000 | 20,194,697 | 2.62% | 0.01% |
| Dec. 23, 2024 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | A | Common Stock | 41408 | $0.00 | 52,991.0000 | 20,069,432 | 357.49% | 0.21% |
| Dec. 23, 2024 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | A | Stock Option | 77742 | $0.00 | 77,742.0000 | 20,069,432 | 9999.99% | 0.39% |
| Dec. 19, 2024 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | M | Common Stock | 1964 | $0.00 | 12,160.0000 | 20,069,432 | 19.26% | 0.01% |
| Dec. 19, 2024 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | M | Restricted Stock Units | 1964 | $0.00 | 3,928.0000 | 20,069,432 | 33.33% | 0.01% |
| Dec. 19, 2024 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | F | Common Stock | 577 | $4.75 | 11,583.0000 | 20,069,432 | 4.75% | 0.00% |
| Oct. 3, 2024 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | M | Restricted Stock Units | 3324 | $0.00 | 3,325.0000 | 20,069,432 | 49.99% | 0.02% |
| Oct. 3, 2024 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | F | Common Stock | 976 | $7.83 | 10,196.0000 | 20,069,432 | 8.74% | 0.00% |
| Oct. 3, 2024 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | M | Common Stock | 3324 | $0.00 | 11,172.0000 | 20,069,432 | 42.35% | 0.02% |
| Feb. 15, 2024 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | A | Common Stock | 4000 | $0.00 | 7,848.0000 | 19,899,679 | 103.95% | 0.02% |
| Dec. 19, 2023 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | A | Restricted Stock Units | 5892 | $0.00 | 5,892.0000 | 0 | 9999.99% | 0.00% |
| Dec. 19, 2023 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | A | Stock Option | 5892 | $0.00 | 5,892.0000 | 0 | 9999.99% | 0.00% |
| Oct. 3, 2023 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | F | Common Stock | 976 | $7.06 | 3,848.0000 | 0 | 20.23% | 0.00% |
| Oct. 3, 2023 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | M | Restricted Stock Units | 3324 | $0.00 | 6,649.0000 | 0 | 33.33% | 0.00% |
| Oct. 3, 2023 | OptimizeRx Corp | $OPRX | Besch Doug | Chief Product Officer | M | Common Stock | 3324 | $0.00 | 4,824.0000 | 0 | 221.60% | 0.00% |